February 12th 2025
In a randomized clinical trial, omalizumab achieved a 36% treatment success rate for multi-food allergy compared with 19% for oral immunotherapy.
February 12th 2025
Allergy, Asthma, and Immunology Meeting Research Update
February 27th 2013Increased exposure to polycyclic aromatic hydrocarbons in air pollution is associated with certain immune system effects and asthma diagnosis, according to research reported the 2013 Annual Meeting of the American Academy of Allergy, Asthma & Immunology.